Namita Singh, MD, Pediatric Gastroenterology, Seattle, WA

NamitaSinghMD

Pediatric Gastroenterology Seattle, WA

Pediatric Inflammatory Bowel Disease Gastroenterology

Assistant Professor at Cedars-Sinai Medical Center, Pediatric IBD Center

Dr. Singh is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Singh's full profile

Already have an account?

Education & Training

  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterPost-Doctoral Fellowship, Advanced Fellowship in Pediatric IBD Clinical Reaearch, 2013 - 2014
  • University of Washington
    University of WashingtonFellowship, Pediatric Gastroenterology, 2010 - 2013
  • UCLA Medical Center
    UCLA Medical CenterResidency, Pediatrics, 2007 - 2010
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 2007
  • University of CaliforniaB.S., Biomedical Sciences, 2000 - 2003

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2010 - 2021
  • CA State Medical License
    CA State Medical License 2009 - 2018
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Gastroenterology

Awards, Honors, & Recognition

  • Award of Distinction from AGA council Digestive Diseases Week, 2015
  • Clinical Fellows Award for Excellence in Research Cedars-Sinai Medical Center, 2014
  • Fellowship Award CCFA Visiting IBD, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Early infliximab trough levels are associated with persistent remission in pediatric patients with inflammatory bowel disease  
    Singh N, Rosenthal CJ, Melmed GY, Mirocha J, Farrior S, Callejas S, Tripuraneni B, Rabizadeh S, Dubinsky MC, Inflammatory Bowel Diseases
  • Therapeutic drug monitoring in children and young adults with IBD: a practical approach  
    Singh N, Dubinsky MC, Gastroenterology & Hepatology
  • Fecal Microbiota Transplantation via Nasogastric Tube for Recurrent C difficile Infection in Pediatric Patients  
    Kronman MP, Nielson HJ, Adler AL, Giefer MJ, Wahbeh G, Singh N, Zerr DM, Suskind DL, J Pediatr Gastroenterol Nutr, 1/1/2015
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Serum TNF levels influence post-induction infliximab concentrations in IBD patient
    Namita Singh, Marla Dubinsky, Digestive Diseases Week 2015, Washington, DC, 5/19/2015
  • Using a pharmacokinetic dashboard to forecast infliximab levels and predict individualized dosing regimens in IBD patients
    Dubinsky M, Singh N, Mould D, Digestive Diseases Week, Washington D.C., 1/1/2015
  • Single-Center Experience of Vedolizumab in Patients with Inflammatory Bowel Disease: Does Age Matter?
    Morganstern B, Singh N, Targan S, Landers T, Vasiliauskas E, Shih D, Feldman E, Ippoliti A, McGovern D, Dubinsky M, Rabizadeh S, Melmed G, Digestive Diseases Week, Washington D.C., 1/1/2015
  • Join now to see all

Lectures

  • Vedolizumab Use in Pediatric Patients With Inflammatory Bowel Disease 
    Digestive Diseases Week
  • Updates in Celiac Disease 
    1/30/2015
  • Persistent Anemia in a patient with Ulcerative Colitis 
    1/29/2015
  • Join now to see all

Press Mentions

  • IBD Highlights from DDW 2015
    IBD Highlights from DDW 2015November 17th, 2016

Research History

  • Research FellowAdvanced fellow in Pediatric IBD clinical research2013 - 2014

Professional Memberships